Richards Kyle A, Negron Edris, Cohn Joshua A, Steinberg Zoe, Eggener Scott E, Shalhav Arieh L
1 Section of Urology, Department of Surgery, The University of Chicago Medical Center , Chicago, Illinois.
J Endourol. 2014 Nov;28(11):1338-44. doi: 10.1089/end.2014.0360. Epub 2014 Aug 21.
To assess the impact of body mass index (BMI) on perioperative and renal functional outcomes in patients undergoing minimally invasive partial nephrectomy (MIPN).
In our IRB-approved, prospectively maintained clinical database, we identified 1206 patients who underwent kidney surgery from 2002 to 2013. Estimated glomerular filtration rate (eGFR) was obtained at baseline and each follow-up visit. From this group, patients who underwent MIPN with more than 12 months of follow-up were selected. Patients were separated into 4 cohorts based on BMI: normal weight (<25 kg/m(2)), preobese (25-30 kg/m(2)), obese class 1 (30-35 kg/m(2)), and obese class ≥2 (>35 kg/m(2)). Change in eGFR was compared across demographic and clinical variables through linear and logistic regression models.
A total of 235 patients met inclusion criteria with median follow-up of 29 months (interquartile range [IQR] 19, 45). There were no differences in demographic, perioperative, or pathologic features between BMI groups. While controlling for gender, race, Charlson comorbidity score, tumor size, and ischemia time, obese class 1 (odds ratio [OR] 4.68, p=0.019), obese class ≥2 (OR 4.27, p=0.033), and age (OR 1.06, p=0.014) were associated with increased risk of CKD stage ≥3; however, higher baseline eGFR (OR 0.91, p<0.001) was associated with a reduced risk of CKD stage ≥3. While controlling for the same variables, increasing BMI was associated with a significant absolute reduction in eGFR at 1 year (0.38 mL/minute/1.73 m(2) reduction in GFR per 1 kg/m(2) increase in BMI, p=0.009).
MIPN is technically feasible in obese patients with similar perioperative outcomes to nonobese patients. BMI is an independent risk factor for worsening kidney function following MIPN.
评估体重指数(BMI)对接受微创部分肾切除术(MIPN)患者围手术期及肾功能结局的影响。
在我们经机构审查委员会(IRB)批准并前瞻性维护的临床数据库中,我们确定了2002年至2013年期间接受肾脏手术的1206例患者。在基线及每次随访时获取估计肾小球滤过率(eGFR)。从该组中,选择接受MIPN且随访时间超过12个月的患者。根据BMI将患者分为4组:正常体重(<25kg/m²)、超重(25 - 30kg/m²)、1级肥胖(30 - 35kg/m²)和≥2级肥胖(>35kg/m²)。通过线性和逻辑回归模型比较不同人口统计学和临床变量下eGFR的变化。
共有235例患者符合纳入标准,中位随访时间为29个月(四分位间距[IQR] 19, 45)。BMI组之间在人口统计学、围手术期或病理特征方面无差异。在控制性别、种族、Charlson合并症评分、肿瘤大小和缺血时间后,1级肥胖(优势比[OR] 4.68,p = 0.019)、≥2级肥胖(OR 4.27,p = 0.033)和年龄(OR 1.06,p = 0.014)与慢性肾脏病(CKD)≥3期风险增加相关;然而,较高的基线eGFR(OR 0.91,p < 0.001)与CKD≥3期风险降低相关。在控制相同变量后,BMI增加与1年时eGFR的显著绝对降低相关(BMI每增加1kg/m²,GFR降低0.38mL/分钟/1.73m²,p = 0.009)。
MIPN在肥胖患者中技术上可行,围手术期结局与非肥胖患者相似。BMI是MIPN后肾功能恶化的独立危险因素。